683 related articles for article (PubMed ID: 29319278)
1. The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years.
Barbareschi M
G Ital Dermatol Venereol; 2018 Feb; 153(1):102-106. PubMed ID: 29319278
[TBL] [Abstract][Full Text] [Related]
2. Minoxidil: mechanisms of action on hair growth.
Messenger AG; Rundegren J
Br J Dermatol; 2004 Feb; 150(2):186-94. PubMed ID: 14996087
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
[TBL] [Abstract][Full Text] [Related]
4. Hair follicle biology and topical minoxidil: possible mechanisms of action.
Headington JT
Dermatologica; 1987; 175 Suppl 2():19-22. PubMed ID: 3319729
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
[TBL] [Abstract][Full Text] [Related]
6. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
Roberts J; Desai N; McCoy J; Goren A
Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
[TBL] [Abstract][Full Text] [Related]
7. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.
Price VH; Menefee E; Strauss PC
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):717-21. PubMed ID: 10534633
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
[TBL] [Abstract][Full Text] [Related]
9. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
[TBL] [Abstract][Full Text] [Related]
10. Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat.
Tricarico D; Maqoud F; Curci A; Camerino G; Zizzo N; Denora N; Cutrignelli A; Laquintana V; Lopalco A; la Forgia F; Fontana S; Franco M; Lopedota A
Eur J Pharm Biopharm; 2018 Jan; 122():146-157. PubMed ID: 29079420
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of minoxidil in the treatment of androgenetic alopecia is likely mediated by mitochondrial adenosine triphosphate synthase-induced stem cell differentiation.
Goren A; Naccarato T; Situm M; Kovacevic M; Lotti T; McCoy J
J Biol Regul Homeost Agents; 2017; 31(4):1049-1053. PubMed ID: 29254313
[TBL] [Abstract][Full Text] [Related]
12. Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men.
Tsuboi R; Arano O; Nishikawa T; Yamada H; Katsuoka K
J Dermatol; 2009 Aug; 36(8):437-46. PubMed ID: 19691748
[TBL] [Abstract][Full Text] [Related]
13. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J; Hoffmann R; Webster A
Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction.
Meephansan J; Thummakriengkrai J; Ponnikorn S; Yingmema W; Deenonpoe R; Suchonwanit P
Arch Dermatol Res; 2017 Nov; 309(9):729-738. PubMed ID: 28884378
[TBL] [Abstract][Full Text] [Related]
16. Histologic response to topically applied minoxidil in male-pattern alopecia.
Abell E
Clin Dermatol; 1988; 6(4):191-4. PubMed ID: 3214821
[No Abstract] [Full Text] [Related]
17. Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia.
Bao L; Gong L; Guo M; Liu T; Shi A; Zong H; Xu X; Chen H; Gao X; Li Y
J Cosmet Laser Ther; 2020; 22(1):1-7. PubMed ID: 29028377
[No Abstract] [Full Text] [Related]
18. The stumptailed macaque as a model for androgenetic alopecia: effects of topical minoxidil analyzed by use of the folliculogram.
Brigham PA; Cappas A; Uno H
Clin Dermatol; 1988; 6(4):177-87. PubMed ID: 3063370
[No Abstract] [Full Text] [Related]
19. Use of topical minoxidil therapy for androgenetic alopecia in women.
Jacobs JP; Szpunar CA; Warner ML
Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
[TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
